Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$0.13 CAD
Change Today +0.02 / 19.05%
Volume 97.5K
ATE On Other Exchanges
As of 3:56 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Daniel Marcel Legault L.L.B.

Chief Executive Officer, President, Secretary, Director and Member of Audit & Corporate Governance Committee,Antibe Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 33 board members in 2 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Daniel Marcel Legault, also known as Dan, L.L.B has been the Chief Executive Officer and President of Antibe Therapeutics Inc. since August 2005 and serves as its Secretary. Mr. Legault has extensive strategic management experience. He is the Founding Principal and Managing Director of Revelstoke Partners, a Toronto-based merchant bank focused on assisting companies in challenging situations, ranging from sophisticated, later-stage startups approaching commercialization ...

Read Full Background

Corporate Headquarters*

15 Prince Arthur Avenue
Toronto, Ontario M5R 1B2


Phone: --
Fax: --

Board Members Memberships*

Chief Executive Officer, President, Secretary, Director and Member of Audit & Corporate Governance Committee


Queen's University

Other Affiliations*

Annual Compensation*

Total Annual CompensationC$261,625

Stock Options*

Total Value of OptionsC$373,100
Total Number of Options890,000

Total Compensation*

Total Annual Cash CompensationC$261,625
Total Short Term CompensationC$261,625
Total Calculated CompensationC$295,111
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATE:CN C$0.13 CAD +0.02


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANTIBE THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at